BioCrossroads
Igniting IN Life Sciences
BioCrossroads is a catalyst for Indiana’s diverse and growing life sciences industry, supporting collaboration, expertise, and investments that fuel innovation and transform global health.
We Advance IN Life Sciences
Through in-depth market research, BioCrossroads uncovers opportunities to fuel collaborative efforts that enhance our innovations and advancements on a global scale.
We Invest IN Life Sciences
We fuel startups and entrepreneurs by providing a supportive ecosystem of mentorship and identifying funding support.
We Engage IN Life Sciences
By collaborating with Indiana’s research institutions, global companies, philanthropic organizations, and government, we connect Indiana’s life sciences community and work to accelerate its success.
Radiopharmaceutical Capital of the World™
With a growing concentration of companies, researchers, and advanced manufacturing capabilities, Indiana is emerging as a hub for radiopharmaceutical innovation and production.
Indiana’s Life Sciences Ecosystem
Advancing BioCrossroads’ 10-Year Strategy
From expanded startup mentoring and capital readiness efforts to radiopharmaceutical manufacturing leadership, biomanufacturing workforce initiatives, and high-impact convenings like the Life Sciences Summit, the 2025 Annual Report highlights how coordinated action across innovation, manufacturing, workforce, and thought leadership is strengthening Indiana’s position as a global hub for life sciences discovery, production, and careers.
Impact IN
2025 IN Life Sciences
Indiana marked a major milestone in 2024, becoming the nation’s top exporter of life sciences products. This achievement, driven by growth in areas like incretin therapies and nuclear medicine, generated more than $99 billion in economic activity. BioCrossroads supported this progress by aligning efforts across the sector and helping to create the conditions for continued innovation and investment.
$102B
statewide economic contribution
$36B
in total life sciences exports
$29.5B
in total pharmaceutical exports
innovate in
70k
employed in life sciences
3,300+
life sciences establishments
$177k
average industry wage
84
new FDA approvals
1,017
new patents granted
36
VC deals
A Strategic Roadmap for Advancing Indiana's Life Sciences Sector
BioCrossroads, in collaboration with TEConomy Partners and key industry stakeholders, worked to develop a refreshed 10-year strategy for the industry. The Strategic Framework for Advancing Indiana’s Life Sciences Industry provides a roadmap for elevating Indiana’s life sciences sector and enhancing our global impact on the ecosystem.
